http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012116861-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee629cf6ed8ce1f50bbc861575a81456
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
filingDate 2012-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e1da2de3b936b0160361ad68a963dc0
publicationDate 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2012116861-A
titleOfInvention GLP-2 preparation
abstract The present invention provides a GLP-2 peptide and an analog preparation thereof exhibiting excellent stability against storage and / or high temperature exposure. GLP- containing a bulking agent selected from the group consisting of phosphate buffer, L-histidine and mannitol and sucrose in an amount sufficient to adjust the pH of the formulation to a physiologically acceptable level. Two peptide formulation. The pH of the preparation is preferably 6.0 or more, more preferably 6.9 to 7.9. The concentration of GLP-2 peptide or an analog thereof is preferably 0.1 to 50 mg / ml. [Selection figure] None
priorityDate 1999-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9943361-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11510170-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158856548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449865931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71300624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10095
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9031
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494052
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2641
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10095
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3772480
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100301982
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426361441
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457585837
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3772194
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9823
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586568
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540157
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548897
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280802
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3771769
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397595
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281122

Total number of triples: 86.